Return to ads
All categories


Posted by
Posting ads for 49 years
Medication risk New Avandia study raises more questions about diabetes Drug maker GlaxoSmithKline and the Canadian Diabetes Association still stand by Avandia's safety record.

Justin Sullivan/Getty ImagesThe diabetes drug is under fire again as the U.S FDA gets ready to examine its risks and benefitsShare with friendsCloseEmail Please enter a valid e-mail addressPlease enter a comma delimited list of valid e-mail addressesOther ways of sharing:Tweet this on TwitterShare on FacebookAdd to DeliciousSubmit post to Digg.comSeed this post at NewsvinePrint or LicenseClosePrint this pageLicense this storyWhats this?By clicking "Recommend", you can recommend this story and share it with your Facebook friendsRead More Dont show this againSee also: Health Canada report: Adverse drug reports up 35 per cent in 2009 Avandia poses a greater risk of heart failure than its counterpart 'Sensible' assumptions put public at risk

Reply to this ad
Recently viewed ads
Saved ads
Please log in to browse your saved adverts or sign up if you don't have an account yet.
Popular Stuff